Resectable adenocarcinoma developing in the remnant pancreas 7 years after partial pancreatoduodenectomy for invasive ductal adenocarcinoma of the pancreas: a case report

BACKGROUND: Pancreatic adenocarcinoma still has an excessively high mortality rate and resection is the only potentially curative treatment. The postoperative 5-year survival rate is approximately 20% and recurrence develops generally within 2 years. We report a case of a localized recurrent pancrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Frei, Lina, Stieger, Ruedi, Bayerl, Christian, Breitenstein, Stefan, Staerkle, Ralph F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513331/
https://www.ncbi.nlm.nih.gov/pubmed/28716115
http://dx.doi.org/10.1186/s13256-017-1359-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513331/
https://www.ncbi.nlm.nih.gov/pubmed/28716115
http://dx.doi.org/10.1186/s13256-017-1359-3

Ejemplares similares